Most Recent
Celgene drops patent suit against Dr Reddy’s over Revlimid generic
Bristol-Myers Squibb unit Celgene has dropped a lawsuit accusing Indian generics company Dr Reddy's Laboraties of threatening to infringe its patent for Revlimid with the planned launch of a generic version of the blockbuster cancer drug in Australia.
High Court won’t save Lex Greensill from tax on $58M in capital gains
The High Court has shot down Greensill founder Lex Greensill's bid for special leave to challenge a finding that he owes tax on $58 million in capital gains, including income from the sale of shares in the collapsed UK-based supply chain finance company.
Judgment leaves ‘thousands of businesses’ with valid COVID-19 claims, class action lawyer says
An appellate victory by insurers in a test case over business interruption coverage for losses stemming from the COVID-19 pandemic does not spell the end to class actions brought on behalf of businesses whose claims were denied, according to a lawyer for the class actions.
Noumi to foot Blue Diamond’s legal bill as part of $48M settlement
Noumi, formerly known as Freedom Foods, has agreed to pay $860,000 in Blue Diamond Growers' costs as part of a $48 million settlement of a legal spat over a licensing deal to sell Almond Breeze milk, which the food maker unsuccessfully argued should be heard in Australia.
High Court to hear BHP challenge to foreign investors in class action
BHP Group has been granted special leave from the High Court to appeal a ruling that rejected its bid to exclude foreign investors from a shareholder class action over the 2015 Fundao dam disaster.
Priceline class action on verge of collapse as funder withdraws
The funder that was bankrolling a class action alleging pharmacy giant Priceline exercised an "overly prescriptive level of control" on franchisees which limited their profitability has withdrawn its support for the proceeding.
New funder signs on for Mesoblast shareholder class action
A new funder is backing a shareholder class action that will be brought against Australian regenerative medicine company Mesoblast over disclosures related to its Remestemcel-L treatment for COVID-19 complications.
Supreme Court judge accused of sexually harassing associates identified as Peter Vickery
Peter Vickery QC has identified himself as the former judge of the Victorian Supreme Court who an investigation found had sexually harassed two of his associates, including by writing sexualised poetry and making unwelcome sexual advances.
Viterra to pay $168.9M for misleading Cargill during Joe White sale
Grain producer Viterra will be ordered to pay Cargill Australia $168.9 million after a judge found the Glencore-owned company  misrepresented the performance capabilities of malt producer Joe White when it sold the company for $420 million in 2013.
Law firm accused of giving bad tax advice on $3B Wyndham Vale development
Melbourne farmers-turned-developers the Bozzo family have sued a national law firm for allegedly giving bad tax advice on the $3 billion Wyndham Vale development in Melbourne's west, situated on 482 hectares of land the family purchased in 1994.